Blood Screening Market is anticipated to reach USD 5.5 billion in 2031 | Abbott Laboratories, Inc. (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US)

New York, The blood screening market size was USD 2.8 billion in 2021 and it is anticipated to reach USD 5.5 billion in 2031, growing at a CAGR of 6.9% from 2022-2031.

Global Blood Screening Market report from Global Insight Services is the single authoritative source of intelligence on Blood Screening Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10245/

Blood screening is a medical process in which blood is examined for a specific disease or condition. It aids in monitoring disease and preventing health issue and a variety of other conditions such as infection and cancer. Human Immunodeficiency Virus (HIV), blood type, and pregnancy screenings are the most common types of blood screening.

Market Trends and Drivers
The key factor boosting the market growth is an increasing number of blood donations across the globe. There is an increase in the need for donated blood owing to advancements in healthcare systems and the availability of and the need for sophisticated surgical procedures, like cardiovascular & transplant surgery, trauma care, and therapy for cancer and blood diseases. On an average around 235 million major surgeries are being performed across the globe every year, of which 63 million are traumatic surgeries, cancer-related are over 31 million, and 10 million are related to pregnancy complications. Blood transfusion is generally prescribed in complicated childbirth to prepare for childhood congenital maternal blood disorders, acute anemia, and trauma.

Major Players of the Global Blood Screening Market
The global blood screening market report comprises key players such as Grifols (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories, Inc. (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), Beckman Coulter, Inc. (Danaher) (US), DiaSorin (Italy), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), Ortho Clinical Diagnostics Inc. (US), GE Healthcare (US), Merck KGaA (Germany), PerkinElmer (US), Bio-Techne Corporation (US), GFE (Germany), Trinity Biotech (Ireland), Mindray (China), Maccura Biotechnology Co., Ltd. (China), Immucor, Inc. (US), Cellabs (Australia), Abnova Corporation (Taiwan), Enzo Biochem, Inc. (US), and Cepheid (US).

Read more about Blood Screening Market here: https://www.globalinsightservices.com/reports/blood-screening-market/

Global Blood Screening Market Segmentation
The report analyses the blood screening market based on product & service, technology, end user, and region.

Global Blood Screening Market by Product & Services

On the basis of product & services, it is segmented into reagents & kits, instruments, and software and services. The reagents and kits segment is likely to dominate the market during the forecast period 2022-2031. The increase in blood transfusion procedures leads to the higher consumption and frequent use of reagents & kits in blood screening procedures. Is boosting the growth of the market.

Global Blood Screening Market by Technology

Based on technology, it is segmented into the nucleic acid test, ELISA, rapid tests, western blot assays, and next-generation sequencing. The nucleic acid test segment is likely to dominate the market in 2021. The key factors such as increasing adoption of NAT technology owing to higher sensitivity over other blood donations are boosting the growth of the market.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10245/

Global Blood Screening Market by End User

Based on end user, it is segmented into blood banks and hospitals. The blood bank segment is likely to dominate the market during the forecast period. The increasing number of organ transplantation surgeries is boosting the growth of this segment during the forecast period.

Geographical Analysis of Global Blood Screening Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is accounted for the higher share of the blood screening market. The growth of the market is attributed to the increasing healthcare spending combined with the increasing prevalence of chronic disorders, the increasing healthcare spending, the increasing prevalence of chronic disorders, and the highly developed healthcare system in the US and Canada.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10245/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.